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There has been little research looking specifically at the reasons for the timing of when men are diagnosed with 
prostate  cancer.  This study investigated the profile of men diagnosed in Greater Glasgow over a two-year period 
(2008-9).  This report explores the experiences of men before they were diagnosed  and includes what triggered 
them or prevented them from presenting their symptoms to a healthcare professional.  The study is based on clinical 
information of the patient population, a postal survey and interview data.
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•	 Older	men	were	more	likely	to	receive	a	high	risk	diagnosis.
•	 Eighty-three	percent	of	men	experienced	one	or	more	symptom.		Of	those	men,	85%	reported	experiencing	them	for	over	
four	weeks,	with	41%	experiencing	symptoms	for	over	a	year.	
•	 The	most	common	route	to	diagnosis	for	respondents	was	presenting	to	a	healthcare	professional	with	symptoms	(48.3%).		
•	 There	was	no	statistically	significant	relationship	between	the	length	of	time	men	experienced	symptoms	before	diagnosis	
and clinical risk.  
•	 Forty	men	(13%)	approached	their	GP	and	requested	a	PSA	test.		These	men	were	statistically	significantly	more	likely	to	be	
from the least deprived backgrounds. They were also more likely to have low clinical risk disease, be asymptomatic and to 
have a friend with prostate cancer.
•	 Men	gain	knowledge	of	the	disease	from	informal	channels	such	as	family	or	friends.
•	 Age	and	family	history	were	not	integrated	into	men’s	perceptions	of	their	overall	risk	of	developing	prostate	cancer
Key Findings
Prostate	 cancer	 is	 the	most	 common	cancer	 in	men	 in	 the	UK	 (Office	 for	National	 Statistics,	 2010)	 and	mainly	 affects	 	older	
men. The median age at diagnosis is 68 years (Droz et al., 2010). Recent evidence suggests that men from low socioeconomic 
backgrounds are significantly more likely to present with advanced prostate cancer (Greenlee and Howe, 2009) and have lower 
survival	 rates	 (Jeffreys	et	al.,	2009).	However,	prostate	cancer	 is	 seen	as	a	‘disease	of	affluence’	due	 to	higher	 incidence	 rates	
among	more	affluent	populations	(Coleman	et	al.,	2004).
Delay:  Delay is mainly associated with the time from first experiencing symptoms to presenting them to a healthcare professional. 
There is accumulating evidence regarding the triggers and barriers to presenting with cancer symptoms and the reasons for 
delayed diagnosis (Corner et al., 2006; Ramirez et al., 1999).  However, the specific reasons for late presentation in prostate cancer 
are	still	under-researched.		Family	members	appear	to	play	an	important	role	in	encouraging	help-seeking	behaviour	(Smith	et	
al.,	2005).	In	addition,	the	existence	of	co-morbid	conditions	can	impact	on	delay.		Men	may	be	regularly	accessing	primary	care	
thus	reducing	their	delay	(Macdonald	et	al.,	2006),	alternatively	they	may	attribute	symptoms	to	an	existing	condition	which	
masks	the	disease	and	thus	increases	time	to	presentation	(Molassiotis	et	al.,	2010).
Risk perception:		People	who	feel	less	at	risk	of	cancer	are	less	likely	to	report	promptly	to	a	GP.		Many	men	believe	they	are	at	low	
risk	of	prostate	cancer	(Fitzpatrick	et	al.,	2009).	Perceived	risk	is	likely	to	be	based	on	a	knowledge	of	the	risk	factors	of	prostate	
cancer	such	as	being	older	and	having	a	family	history	of	the	disease	(Johns	and	Houlston,	2003),	as	well	as	beliefs	about	the	
common symptoms of prostate cancer. 
Knowledge:  Studies assessing awareness and knowledge of prostate cancer have produced conflicting results with some 
reporting	poor	awareness	 (Fitzpatrick	et	al.,	1998)	while	more	recent	research	has	found	better	knowledge	 levels	 (Fitzpatrick	
et al., 2009; Hevey et al., 2009). There is agreement, however, that the better informed someone is, the more likely they are to 
present	sooner	in	the	event	of	experiencing	symptoms	which	match	their	expectations	for	the	disease	(Fitzpatrick	et	al.,	1998;	
Sunny et al., 2008). 
Symptoms:  Related to knowledge, is awareness of cancer-related symptoms and symptom interpretation.  There is consensus 
across	the	cancer	literature	that	onset	of	vague	non-specific	symptoms	can	lead	to	greater	delay	(Molassiotis	et	al.,	2010).	This	is	
particularly relevant in prostate cancer where symptoms generally have a slow, gradual onset.  The nature of the symptoms can 
also	prompt	help-seeking	behaviour,	with	symptoms	perceived	as	‘more	serious’,	e.g.	bleeding,	resulting	in	faster	presentation	
(Macleod	et	al.,	2009).
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A	postal	 survey	was	 sent	 to	 all	men	 in	Greater	Glasgow	who	were	 diagnosed	with	 prostate	 cancer	 in	 2008/9	 (N=458).	
The	survey	was	returned	by	320	men;	a	response	rate	of	70%.	Thirty	men	(and	their	partners,	where	possible)	were	also	
interviewed.  The survey data were analysed with statistics and the interview data were analysed to identify  themes.  Clinical 
risk	was	defined	using	criteria	from	the	STAMPEDE	trial	(James	et	al.,	2009)	which	classifies	men	as	high-risk	based	on	clinical	
markers	from	blood	tests,	biopsies	and	whole-body	scans	(Gleason,	PSA	and	TNM	scores).
Methods
Findings
Total patient population sample:  
The total patient population had an average age 
of 69.  Thirty-six percent of men were classified as 
having a high-risk prostate cancer. The total patient 
population	 for	 2008/9	 included	 more	 men	 from	
affluent	 areas,	 indicating	 that	 men	 from	 deprived	
backgrounds	 were	 diagnosed	 less	 frequently.	 	
Deprivation was not associated with higher clinical 
risk.	Age,	however,	was	associated	with	clinical	risk,	
with older men more likely to receive a high-risk 
diagnosis. 
Symptom experience:  
Eighty-three	 percent	 of	 men	 experienced	 one	 or	
more symptoms prior to their diagnosis. Symptoms 
were	 often	 related	 to	 urinating.	 Eighty-five	 percent	
of men who reported symptoms had experienced 
them	 for	 over	 four	 weeks,	 with	 41%	 experiencing	
symptoms for over a year. There was no statistically 
significant relationship between the length of time 
men experienced symptoms before diagnosis and 
their clinical risk at diagnosis.  
Despite many men considering their symptoms to be 
troublesome	 (57%),	 this	 did	 not	 act	 as	 a	 prompt	 for	
men	 to	 go	 to	 the	 GP.	 	 However,	 men	 who	 reported	
feeling	that	their	symptoms	were	worrying	(49.8%)	or	
serious	(24.5%)	were	more	likely	to	seek	help	faster.	
I eventually was passing blood.  And that’s when 
I went to the doctor again.  (Participant 38)
Men’s	 medical	 history	 influenced	 how	 they	 understood	
their	 symptoms.	Men	who	had	a	history	of	urinary	 tract	
infections presented later than men without such a 
medical	 history.	 Men	 with	 benign	 prostatic	 hyperplasia	
(a non-cancerous prostate condition) were likely to 
explain their symptoms with reference to this co-morbid 
condition.
Participant 451:  I would say I knew a year before 
that there was something wrong but I just didn’t 
know what it was. 
Interviewer:  Oh really? What was going through 
your mind then? 
Participant 451:  I just, I just put it down to, well 
maybe it’s old age or something like that.  
Routes to gaining a diagnosis:
The most common route to diagnosis was presenting to 
a	 healthcare	 professional	 with	 symptoms	 (48.3%).	 The	
majority	 (83%)	 of	 those	who	did	 approach	 a	 healthcare	
professional	 experienced	 no	 delay	 in	 testing/referral	 for	
testing.  This is favourable compared with recent national 
statistics	(National	Cancer	Intelligence	Network,	2010).		
By the time I’d actually seen the doctor was when 
things started rolling, I won’t consider there to be 
any delay.  (Participant 91)
Men	who	had	blood	 in	 their	 urine	or	 semen	were	 likely	
to perceive their symptoms as serious and to seek help 
quickly.	 	They	were	unlikely	 to	attribute	 their	 symptoms	
to normal ageing. 
Men	 who	 explained	 their	 symptoms	 (most	 commonly	
changes in urination) as being part of normal ageing 
were significantly more likely to have experienced those 
symptoms for over 12 months before seeking help.
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This finding was supported during interviews post-diagnosis 
as	many	men	reported	that	they	now	encourage	their	friends/
relatives to be tested.
A	 number	 of	men	 (14.8%)	 reported	 attending	 the	 GP	 for	
another reason and mentioning their symptoms whilst 
there.  This is related to the high incidence of co-morbid 
conditions	in	our	sample	(74%).
Forty	 men	 (13%)	 approached	 their	 GP	 and	 requested	 a	
PSA	blood	 test.	 	These	men	were	 significantly	more	 likely	
to	be	from	the	most	affluent	backgrounds.	They	were	also	
more likely to have low clinical risk disease, and to have no 
symptoms. These same men were significantly more likely 
to have a friend who had prostate cancer, and slightly more 
likely to have a family history of prostate cancer.  
One of my colleagues, he stays in the Ukraine, 
he’s an Englishman, he had been diagnosed 
with it and he was working with me at the time. 
So we got talking, you know … and he says “It 
would be advantageous,” he says, “at your age, 
to just go and ask the doctor for a PSA.” 
(Participant 157)
Family	 and	 friends	 were	 important	 in	 prompting	 men	 to	
visit	their	GP	with	symptoms,	with	27%	of	men	citing	this	as	
the reason they attended primary care. 
People I meet socially as well, most of them now 
have had their tests done.  (Participant 14)
Because of you?  (Partner 14)
How many men would you say that you’ve 
advised?  (Interviewer)
Oh ... certainly double figures, well, well, well into 
double figures.  (Participant 14) 
Closer to 50 or closer to 20? (Interviewer)
Well over 20 but maybe not as much as 50. 
(Participant 14)
I was telling him (friend) about the … the trouble 
I had with peeing and the embarrassment etc. 
and he says “If you don’t mind,” he says, “I’ve 
got prostate cancer and it sounds like the start 
of prostate.” He says, “That’s how I was,” he says, 
“Yeah, you’re going to toilet then two minutes 
later you’re running back to the toilet.” He said, 
“I’d get it checked out.” (Participant 77)
Knowledge of prostate cancer:  The majority of men 
reported having no knowledge of prostate cancer prior to 
diagnosis	(64%).		Despite	the	majority	of	men	experiencing	
symptoms, few sought information relating to these 
symptoms	(21%).
In hindsight … I delayed because I didn’t know 
anything about prostate problems, you know. I 
just assumed that what I had was something that 
was, that would clear up. And therefore I didn’t 
have to push it with the doctor. (Participant 27)
Of	those	who	reported	some	knowledge	of	the	disease,	the	
majority	 (69%)	knew	someone	with	prostate	cancer	 (PCa)	
before they were diagnosed.  This is reflected in the finding 
that the most common source of knowledge was from 
informal	channels	such	as	family	or	friends	(36%).
Perceptions of risk:  The main risk factors for prostate 
cancer are age and family history of the disease. However, 
few	respondents	(n=21;	7%)	considered	themselves	to	be	at	
high	risk	of	prostate	cancer.		Men	in	the	older	age	categories	
were no more likely to perceive themselves as at high risk 
than younger men. Those with a family history of prostate 
cancer	 (11%)	 were	 only	 slightly	 more	 likely	 to	 perceive	
themselves at high risk but there was not a significant 
difference.
Men’s	 knowledge	 of	 risk	 factors	 for	 prostate	 cancer	 are	
low.	 	Men	 are	 often	 prompted	 to	 seek	 tests	 from	primary	
care following conversations with friends and family.  This 
means that health promotion messages could be tailored to 
use relationships to drive communication and information 
about clinical risk factors, leading to earlier diagnosis of 
cancers.
Policy and Practice Recommendations
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